Telcare has received the go-ahead in Europe to market its blood glucose meter, which already has marketing clearance in the U.S. The device is equipped with cellular functionality to allow clinicians to access patient glucometer readings, monitor their progress and send recommendations on diet, exercise and other data remotely.

Full Story:

Related Summaries